Skip to content


In vivo osteoprotegerin gene therapy preventing bone loss induced by periodontitis

ConclusionLocal recombinant OPG plasmid?mediated gene therapy suppresses osteoclastogenesis in vivo and inhibits alveolar bone height reduction caused by experimental periodontitis in rats. OPG gene therapy may be beneficial in preventing progressive periodontal bone loss. (Source: Journal of Periodontal Research)

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

MedWorm: Dentistry

Posted in Dental News.

Tagged with , , , , , , , , .